Catalent Inc
NYSE:CTLT
Catalent Inc
Common Shares Outstanding
Catalent Inc
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Catalent Inc
NYSE:CTLT
|
Common Shares Outstanding
$180m
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Johnson & Johnson
NYSE:JNJ
|
Common Shares Outstanding
$2.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Shares Outstanding
$2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Pfizer Inc
NYSE:PFE
|
Common Shares Outstanding
$5.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
Merck & Co Inc
NYSE:MRK
|
Common Shares Outstanding
$2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Shares Outstanding
$950.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Catalent Inc's Common Shares Outstanding?
Common Shares Outstanding
180m
USD
Based on the financial report for Mar 31, 2024, Catalent Inc's Common Shares Outstanding amounts to 180m USD.
What is Catalent Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
9%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Catalent Inc have been 2% over the past three years , 4% over the past five years , and 9% over the past ten years .